| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |